Follicle Stimulating Hormone Levels During Androgen Deprivation Therapy Are Not Associated With Survival or Development of Castration-Resistant Prostate Cancer

Follicle Stimulating Hormone Levels During Androgen Deprivation Therapy Are Not Associated With Survival or Development of Castration-Resistant Prostate Cancer

BackgroundFollicle-stimulating hormone (FSH) dysregulation plays a potential role in prostate cancer progression. The objective of this study was to evaluate whether higher FSH levels during androgen deprivation therapy (ADT) for recurrent prostate cancer could predict the development of castration-...

Full description

Saved in:
Bibliographic Details
Main Authors: Kaleem Atchia, France-Hélène Joncas, Lily Summers Trasiewicz, Wei Phin Tan, Keyue Ding, Brant A. Inman, Paul Toren
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Société Internationale d’Urologie Journal
Subjects:
follicle-stimulating hormone
biomarker
androgen deprivation therapy
oncologic outcomes
prostate cancer
Online Access:https://siuj.org/index.php/siuj/article/view/171/101
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://siuj.org/index.php/siuj/article/view/171/101

Similar Items